Harvard Drug Policy Experts Write in JAMA About How Congress Could Fix 340B Contract Pharmacy Mess

screenshot of 340B drug pricing program article in JAMA
"Contract pharmacy restrictions are the latest problem with implementation of the 340B program that threaten to undermine its laudable goals," three Harvard drug policy experts say in an opinion article in JAMA.

A nationally prominent drug policy expert and two colleagues at Harvard Medical School have written in JAMA how Congress could end the fight over 340B contract pharmacy and enhance 340B program integrity.

“First, Congress could explicitly allow the participation of

Read More »

At Direction of U.S. Appeals Court, Judge Issues Amended Judgement in Lilly’s 340B Contract Pharmacy Case

Senior District Court Judge Sarah Evans Barker
It is unknown whether U.S. Senior District Judge Sarah Evans Barker’s amended partial final judgement in Lilly's 340B contract pharmacy lawsuit will satisfy a higher court that kicked the case back to her.

A federal district judge in Indianapolis last week responded to a higher court’s directive and entered an amended partial final judgement in drug manufacturer Lilly’s 340B contract pharmacy lawsuit. It is not clear whether the judge did enough to satisfy

Read More »
Industry Insights Logo

AHF Provides Stigma-Free Care with Thrift Store Chain

Asha Doucet headshot on light blue background

SPONSORED CONTENT

The AIDS Healthcare Foundation thrift store division, Out of the Closet, presents a fun, stigma-free opportunity to link people to care. Every Out of the Closet thrift store benefits AHF’s life-saving programs around the world because 96 cents of every dollar

Read More »

Sanofi Makes Two Big Changes to its 340B Contract Pharmacy Policy

Sanofi outdoor building sign
Changes to Sanofi's 340B drug pricing conditions may eliminate 340B discounts for health centers using multiple contract pharmacies within a chain.

Drug manufacturer Sanofi has made two major changes to its conditions on 340B pricing when health centers and certain hospitals and use contract pharmacies, a company spokesperson confirms. One is raising flags among 340B providers and the other appears to

Read More »

BMS Fleshes Out How It Will Use Claims Data for 340B Myeloma Drug Purchases

Bristol Myers Squibb exterior sign
BMS has released its terms of use for the claims data providers must give it in exchange for access to 340B pricing on Revlimid, Pomalyst, and Thalomid.

Bristol Myers Squibb has disclosed its terms of use for the drug claims data that providers must give it in exchange for access to 340B pricing on BMS’s oral oncology drugs Revlimid, Pomalyst, and Thalomid.

BMS acquired the three drugs

Read More »
Industry Insights Logo

How Sentry Is Helping Covered Entities Contend With Contract Pharmacy Exclusions

SPONSORED CONTENT

With more and more drug manufacturers excluding their products from 340B contract pharmacies, covered entities are asking two questions: When does this end? And what should we do about it? At Sentry, we’re asking ourselves, how can we best support our customers in these

Read More »

340B Providers Say Express Scripts’ New 340B Claims Validation Requests Raise Red Flags

Express Scripts office building
340B covered entities have raised concerns about Express Scripts' new requests to verify 340B drug reimbursement claims.

340B hospitals and health centers say they have a lot of questions about new requests from Express Scripts (ESI) to verify 340B drug reimbursement claims in 10 business days.

Hospital and health center covered entities report getting one or more

Read More »

Feds Tell Court Tennessee Health System Paid for Referrals to Recoup “Staggering” 340B Discounts

Methodist University Hospital building mounted sign
The federal government told a court this week that Methodist Le Bonheur Healthcare agreed to pay a private oncology practice "for referrals and the opportunity to recoup discounts through the 340B program." Methodist has vowed to vigorously defend itself against what it says are meritless claims.

The federal government on Monday accused a Tennessee health system of unlawfully paying a Memphis-area private oncology practice for patient referrals, letting the system “recoup a staggering discount in costs” through the 340B program. The 340B health system—Methodist Le Bonheur

Read More »
Industry Insights Logo

The Right Prescription: How a Pharmacy Management Partner Can Alleviate Your Workforce Woes

SPONSORED CONTENT

Managing a hospital, clinic or specialty pharmacy grows more challenging with each passing day. Whether you are considering opening a new pharmacy or already operate one or multiple locations, existing and emerging complexities challenge daily pharmacy operations and financials.

Research conducted by

Read More »

Feds Appeal Court Ruling in AstraZeneca’s 340B Contract Pharmacy Lawsuit

AstraZeneca building sign
The federal government is appealing a lower court's ruling in AstraZeneca’s 340B contract pharmacy lawsuit.

The federal government, as expected, is challenging a federal district judge’s February opinion and March final orders in drug manufacturer AstraZeneca’s 340B contract pharmacy lawsuit.

The U.S. Justice Department (DOJ) announced the appeal in a one-sentence court filing on April

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live